Boehringer Ingelheim Expands Biopharmaceutical Fill and Finish Capabilities

Boehringer Ingelheim is expanding its capacities and capabilities in fill and finish for biopharmaceuticals at its state-of-the-art facility in Biberach, Germany, with a new filling line. The new line is available as of today for contract filling of liquid and lyo vials from 0.5ml – 100ml. The expansion to a combination line for single and double chamber cartridges will be up and running in Q4 2012.

To meet customer demand for clinical and commercial scale filling the batch sizes range from 6,000 – 110,000 for vials and 50,000 – 100,000 for carpoules.

The new line with isolator technique represents one further step in Boehringer Ingeheim’s one stop shop for contract development and manufacturing of biopharmaceuticals. With this state-of-the-art technology Boehringer Ingelheim offers further excellence and solutions in the contract manufacturing business to its customers in addition to the existing capacities for lyophilization, vial filling and filling in pre-filled syringes. Customers can rely on Boehringer Ingelheim either as a single supplier or they can also enter at any step in the development.

“As a leader in its field, Boehringer Ingelheim has supported pharmaceutical companies in the successful launch of many biologic drugs,” says Simon Sturge, corporate senior vice president biopharmaceuticals. “I believe that this further expansion will benefit our customers by receiving high-quality drug substance and drug product from one source with very convenient applications which bring
an even higher benefit for the patients.”

More About This Company